First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (FDTS)

NASDAQ: FDTS · Real-Time Price · USD
51.05
-0.25 (-0.49%)
At close: Aug 1, 2025, 4:00 PM
51.05
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:15 PM EDT
-0.49%
Assets$7.79M
Expense Ratio0.80%
PE Ratio9.34
Shares Out150,002
Dividend (ttm)$1.61
Dividend Yield3.14%
Ex-Dividend DateJun 26, 2025
Payout FrequencyQuarterly
Payout Ratio29.27%
Volume178
Open51.16
Previous Close51.31
Day's Range51.05 - 51.16
52-Week Low37.10
52-Week High52.63
Beta0.85
Holdings414
Inception DateFeb 15, 2012

About FDTS

Fund Home Page

The First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (FDTS) is an exchange-traded fund that is based on the NASDAQ AlphaDEX DM Ex-US Small Cap index. The fund tracks a tiered equal-weighted index of 400 small-cap companies selected from the S&P Developed Markets ex-US BMI based on S&P's AlphaDex selection methodology. FDTS was launched on Feb 15, 2012 and is issued by First Trust.

Asset Class Equity
Category Foreign Small/Mid Value
Region Global
Stock Exchange NASDAQ
Ticker Symbol FDTS
ETF Provider First Trust
Index Tracked NASDAQ AlphaDEX DM Ex-US Small Cap Index

Top 10 Holdings

6.49% of assets
NameSymbolWeight
Hanwha Corporation0008800.83%
Hyosung Heavy Industries Corporation2980400.82%
Harel Insurance Investments & Financial Services LtdHARL0.65%
Hyundai Engineering & Construction Co.,Ltd.0007200.65%
Sumitomo Pharma Co., Ltd.45060.61%
Metaplanet Inc.33500.60%
Menora Mivtachim Holdings Ltd.MMHD0.60%
Hanwha Engine Co., Ltd.0827400.59%
Food & Life Companies Ltd.35630.58%
Hankook & Company Co., Ltd.0002400.57%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Jun 26, 2025$0.6186Jun 30, 2025
Mar 27, 2025$0.1232Mar 31, 2025
Dec 13, 2024$0.7166Dec 31, 2024
Sep 26, 2024$0.1503Sep 30, 2024
Jun 27, 2024$0.4994Jun 28, 2024
Mar 21, 2024$0.2036Mar 28, 2024
Full Dividend History

Performance

FDTS had a total return of 24.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.59%.

News

There is no news available yet.